FDA's approval of first oral treatment for postpartum depression is a 'good advance'

Federal health officials have approved the first oral treatment for postpartum depression.

FILE - An estimated one in 7 women suffer from postpartum depression.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

komonews /  🏆 272. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Opinion | Washington Stages a Peacetime Fiscal BlowoutFrom WSJopinion: The federal budget deficit is 131% higher than a year ago so far in fiscal 2023, despite a growing economy and no national emergency
Les mer »

First-ever postpartum depression pill, Zurzuvae, approved by FDAThe FDA on Friday approved the first pill to treat postpartum depression, a condition that data shows affects around 1 in 7 women in the United States.
Les mer »

FDA OKs Talquetamab, a First-in-Class Multiple Myeloma DrugThe FDA has granted accelerated approval to talquetamab-tgvs, a first-in-class bispecific antibody targeting the GPRC5D receptor, for heavily pretreated adults with relapsed or refractory multiplemyeloma. MedicalNews
Les mer »

Expert: FDA's approval of first oral treatment for postpartum depression is a 'good advancFederal health officials have approved the first oral treatment for postpartum depression.
Les mer »

FDA Program Collects Birth Control Data from TeensA federal program is collecting a trove of intimate monthly birth control data on hundreds of thousands of patients, many of whom are teens, including the results of mandatory pregnancy tests.
Les mer »

Nail Care ProductsPlanning on getting a manicure? Beware-some nail hardeners may contain harmful ingredients that may damage nails and cause them to break. For more information on how to use nail products safely, see nails summerfun safety
Les mer »